In cohort 1, LCN2 concentrations in VaD (n = 27) were significantly different from AD (n = 47), SVDND (n = 20), and VCIND (n = 7) (p < 0.01, Tukey contrast for multiple comparisons of means) (Fig. 3a). This evidence concerns the gene LCN2 and Alzheimer disease.